Research programme: cancer immuno-therapeutics - AvipepAlternative Names: ADC-AVP04; ADC-AVP06; Avibody™
Latest Information Update: 25 May 2015
At a glance
- Originator Avipep
- Class Antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 17 Apr 2015 Early research in Cancer in Australia (IV)